TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+8.42%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
+$6.09B
(+5.7%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,445
New
84
Increased
613
Reduced
589
Closed
60
Top Buys
| 1 |
Apple
AAPL
|
+$257M |
| 2 |
UnitedHealth
UNH
|
+$226M |
| 3 |
Colgate-Palmolive
CL
|
+$217M |
| 4 |
Moody's
MCO
|
+$203M |
| 5 |
Curtiss-Wright
CW
|
+$189M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$744M |
| 2 |
Lam Research
LRCX
|
+$339M |
| 3 |
Merck
MRK
|
+$305M |
| 4 |
Vistra
VST
|
+$200M |
| 5 |
ConocoPhillips
COP
|
+$181M |
Sector Composition
| 1 | Technology | 20.68% |
| 2 | Financials | 20.15% |
| 3 | Healthcare | 11.01% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
RLI Corp
RLI
$6.08B
| $2.18M | ﹤0.01% |
28,372
+4,000
| +16% | +$308K |
|
1002
HF Sinclair
DINO
$9.57B
| $2.17M | ﹤0.01% |
47,935
+30,996
| +183% | +$1.4M |
|
|
ORKA
1003
Oruka Therapeutics, Inc. Common Stock
ORKA
$591M
| $2.17M | ﹤0.01% |
+95,076
| New | +$2.17M |
|
1004
Aaon
AAON
$6.93B
| $2.17M | ﹤0.01% |
20,264
-21,600
| -52% | -$2.31M |
|
|
CNR
1005
Core Natural Resources, Inc.
CNR
$3.74B
| $2.17M | ﹤0.01% |
20,800
-500
| -2% | -$52.2K |
|
1006
OGE Energy
OGE
$8.85B
| $2.17M | ﹤0.01% |
53,122
| – | – |
|
1007
Doximity
DOCS
$12.9B
| $2.16M | ﹤0.01% |
+50,400
| New | +$2.16M |
|
1008
Expro
XPRO
$1.42B
| $2.16M | ﹤0.01% |
+126,668
| New | +$2.16M |
|
1009
Antero Resources
AR
$10.1B
| $2.15M | ﹤0.01% |
74,800
-16,000
| -18% | -$459K |
|
1010
DXC Technology
DXC
$2.55B
| $2.14M | ﹤0.01% |
103,300
-15,500
| -13% | -$321K |
|
1011
Varonis Systems
VRNS
$6.31B
| $2.14M | ﹤0.01% |
38,000
-3,800
| -9% | -$214K |
|
1012
Stifel
SF
$11.6B
| $2.14M | ﹤0.01% |
22,800
-1,000
| -4% | -$93.7K |
|
1013
Novanta
NOVT
$4.14B
| $2.13M | ﹤0.01% |
12,096
+400
| +3% | +$70.6K |
|
1014
iShares Russell 1000 Growth ETF
IWF
$119B
| $2.13M | ﹤0.01% |
5,705
-6
| -0.1% | -$2.24K |
|
1015
EastGroup Properties
EGP
$8.72B
| $2.13M | ﹤0.01% |
11,344
-5,400
| -32% | -$1.01M |
|
1016
MACOM Technology Solutions
MTSI
$9.81B
| $2.12M | ﹤0.01% |
19,044
-20,200
| -51% | -$2.25M |
|
1017
W.P. Carey
WPC
$14.8B
| $2.12M | ﹤0.01% |
33,847
+434
| +1% | +$27.2K |
|
1018
CTS Corp
CTS
$1.22B
| $2.12M | ﹤0.01% |
43,876
-4,000
| -8% | -$194K |
|
1019
Idacorp
IDA
$6.76B
| $2.12M | ﹤0.01% |
20,496
+1,800
| +10% | +$186K |
|
1020
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.2B
| $2.1M | ﹤0.01% |
4,970
-800
| -14% | -$338K |
|
1021
Wave Life Sciences
WVE
$1.18B
| $2.09M | ﹤0.01% |
251,806
+67,860
| +37% | +$563K |
|
1022
Thermon Group Holdings
THR
$826M
| $2.08M | ﹤0.01% |
69,632
| – | – |
|
1023
DaVita
DVA
$9.46B
| $2.08M | ﹤0.01% |
12,729
-1,317
| -9% | -$215K |
|
1024
PJT Partners
PJT
$4.37B
| $2.07M | ﹤0.01% |
15,500
-800
| -5% | -$107K |
|
1025
Vontier
VNT
$6.29B
| $2.06M | ﹤0.01% |
60,850
+14,800
| +32% | +$501K |
|